Literature DB >> 4076319

Distribution of phenobarbital in whole blood during pregnancy and perinatally--an in vitro study.

A Wallin, L Herngren.   

Abstract

The distribution of phenobarbital (PB) in whole blood and its fractions in 8 pregnant women, in 10 mothers and infant pairs at delivery and in 7 controls was studied by equilibrium dialysis. The lowest protein binding was in cord plasma. A correlation was found between the maternal and cord plasma PB binding. The adult plasma PB binding ratio was correlated with the molar albumin concentration, but no such relation was found in cord plasma, suggesting inhibition of binding by other factors. As a counterpart to the lower protein binding in maternal and cord plasma, the fraction of PB distributed to erythrocytes in those groups was significantly higher. The apparent concentration of PB in maternal erythrocytes was increased. The distribution of drugs to the various fractions of whole blood is an important consideration perinatally, since the binding characteristics of plasma and blood cells in mother and fetus will be crucial determinants for the placental transfer of drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076319     DOI: 10.1007/BF00547420

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Placental transfer of phenobarbitone in epileptic women, and elimination in newborns.

Authors:  J C Melchior; O Svensmark; D Trolle
Journal:  Lancet       Date:  1967-10-21       Impact factor: 79.321

2.  The distribution and excretion of phenobarbital.

Authors:  W J WADDELL; T C BUTLER
Journal:  J Clin Invest       Date:  1957-08       Impact factor: 14.808

3.  Pentazocine binding to blood cells and plasma proteins.

Authors:  M Ehrnebo; S Agurell; L O Boréus; E Gordon; U Lönroth
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

4.  Disappearance from the newborn of circulating prenatally administered phenobarbital.

Authors:  B Jalling; L O Boréus; N Kållberg; S Agurell
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

5.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

6.  An automated turbidimetric immunoassay for plasma proteins.

Authors:  K Bergström; A K Lefvert
Journal:  Scand J Clin Lab Invest       Date:  1980       Impact factor: 1.713

7.  Increased sodium-lithium countertransport in erythrocytes of pregnant women.

Authors:  R J Worley; W M Hentschel; C Cormier; S Nutting; G Pead; K Zelenkov; J B Smith; K O Ash; R R Williams
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

8.  Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants. A controlled study of bilirubin disappearance and infant behavior.

Authors:  A Wallin; L O Boréus
Journal:  Acta Paediatr Scand       Date:  1984-07

9.  Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions.

Authors:  M P Sheetz; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

10.  Serum protein binding of drugs during and after pregnancy in rats.

Authors:  B Stock; M Dean; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

View more
  2 in total

Review 1.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

2.  Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy.

Authors:  L Herngren; A Nergårdh
Journal:  J Neurol       Date:  1988-11       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.